Allarity Therapeutics Inc. Common Stock ALLR · Stock Open Allarity Therapeutics Inc. Common Stock in new tab
Allarity Therapeutics Inc. Common Stock Analysis (ALLR)
Is Allarity Therapeutics Inc. Common Stock a good investment? Allarity Therapeutics Inc. Common Stock (ALLR) is currently trading at 1.04 USD.
In terms of valuation, the stock trades at a P/E ratio of 0.12. This relatively low multiple may signal that Allarity Therapeutics Inc. Common Stock is undervalued compared to historical market norms.
Earnings Schedule: Allarity Therapeutics Inc. Common Stock is expected to release its next earnings report on Nov. 13, 2026. The market consensus estimate for Forward EPS is -0.86.
Investor FAQ
Does Allarity Therapeutics Inc. Common Stock pay a dividend?
No, it does not currently pay a dividend.
What asset class is Allarity Therapeutics Inc. Common Stock?
Allarity Therapeutics Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 13, 2026. The company currently has a trailing EPS of -0.79.
Company Profile
Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology. Its lead drug candidate is stenoparib, a dual inhibitor of poly-ADP-ribose polymerase (PARP1/2), which is in a Phase 2 clinical trial for patients with advanced and recurrent ovarian cancer. It is also developing stenoparib with temozolomide, a PARP and WNT inhibitor in combination with a DNA-alkylating chemotherapy agent, which is in a Phase 2 clinical trial for patients with relapsed small cell lung cancer; and stenoparib-DRP, a companion diagnostic product used to select patients for stenoparib treatment. Allarity Therapeutics, Inc. is headquartered in Tarpon Springs, Florida.
| Split Date | Split Ratio to 1 |
|---|---|
| March 27, 2023 | 1:35 |
| June 29, 2023 | 1:40 |
| April 9, 2024 | 1:20 |
| Sept. 11, 2024 | 1:30 |
Community Discussion